Iván Pinos Cabezas

Indefinite suspension of my activity on X. I will be migrating to @bluesky.
You can follow me there @pinosi91.bsky.social

[Iván Pinos Cabezas @ivan_pinos]

Announcing the indefinite suspension of my activity on X. I will be migrating to @bluesky.
You can follow me there @pinosi91.bsky.social

#Xodus #LeaveX #joinbluesky

[Itai Yanai @ItaiYanai]

How to write a grant?
1. Write it for the reviewer, not you, the applicant.
2. Communicate in stories.
3. Make your story cohesive—leave no puzzling gaps.
4. Make your story resonate to keep the reviewer reading.
5. Accept chance and noise in peer-review.
https://t.co/wHZ065DNlm

[Iván Pinos Cabezas @ivan_pinos]

Immensely happy and proud of my fella @GNavalon for publishing in @Nature!! Your curiosity and scientific enthusiasm is really contagious and the reason why I became a researcher. Kudos to you and your team!! 🎉🥳👏🏻

[Guillermo Navalón @GNavalon]

Tired of flattened early bird fossils?

Today is your lucky day.

Very happy to finally welcome 'Navaornis hestiae' to the world! It allowed us to see for the first time a (near)complete enantiornithine brain.

Today in @Nature: https://t.co/rVj52qzkNH

#spinningskull

[Yanina Pepino @YaniPepino]

Are you looking for a lab to do a post-doc? Apply to join us!

https://t.co/YNwWVjzUBB

[eLife - the journal @eLife]

🧵 Thread of free tools and guidance for scientists

💡 Covering research skills, careers, #SciComm, leadership, activism and more, our Learning Resources page has tips for researchers and academics at any career stage. #AcademicChatter #ECRChat 1/n
​​https://t.co/3zslO5AoHw

[Marcin Sowa @xmsowa]

🎉Excited to share my first first-authored paper as a postdoc📰!
We explored the impact of antiplatelet therapy on megakaryocyte and platelet transcriptomes. Check it out: https://t.co/l8pZPdomiI.
@PlateletDoc @TessaJBarrett @nyugrossman @NYULH_postdocs #JACCBTS @JACCJournals

[Arthur Liesz @ArthurLiesz]

Finally out today! Very proud of this story:

Innate immune memory after Stroke drives remote organ pathology

This study was led by superstar-postdoc @SimatsAlba and X-less Sijia Zhang. @CellCellPress

https://t.co/0pvrxibv6P

[Glenn Fishman @glennfishman]

#1 in New York and #2 in the Nation according to U.S. News & World Report! So proud of our faculty, fellows and staff @nyulangone who strive each and every day to provide world-class cardiovascular care.

[Iván Pinos Cabezas @ivan_pinos]

When your PI surprises you with the cutest and best birthday gift for a cardiovascular researcher! Thank you @TessaJBarrett 🤩🫀🧑🏻‍🔬

[Itai Yanai @ItaiYanai]

Science is not really happening when the goal is a paper, a presentation, a grant, or any product. It only really happens when the goal is a process of discovery.

[Iván Pinos Cabezas @ivan_pinos]

Imagining these beautiful megakaryocytes (🟣) in the bone marrow 🔬🐁

[Iván Pinos Cabezas @ivan_pinos]

I am thrilled and honored to participate in this year’s CVRC Annual Symposium! Looking forward to sharing groundbreaking science with my colleagues tomorrow! 🧑🏻‍🔬🤩 @NYULHCVRC

[Iván Pinos Cabezas @ivan_pinos]

@AnaMarinQuilez @crh_MoralesIMIB @FFIS_CARM @GEAPC1 @JosRiveraPozo2 Enhorabuena Ana!! 👏🏻👏🏻

[eLife - the journal @eLife]

🔬 Condensates: When fixation creates fiction

A chemical regularly used to image cells can dramatically alter the way cellular compartments called condensates look under the microscope. 12/13
https://t.co/MblaT6Hvfi

[NIH @NIH]

Wondering how the new simplified peer review framework will impact existing and new funding opportunities? Join #NIH experts on April 17 to learn more, including a live Q&A: 💻🔍🗓️ https://t.co/1jOnKEX3xD

[Iván Pinos Cabezas @ivan_pinos]

I'm doing the Bike 100 Miles Challenge for the @American_Heart American Heart Association! Please support me as I raise funds by taking on biking 100 miles to help end heart disease and stroke. Thank you, everyone!
https://t.co/dyoDb7bjlH

[RPTH @RPTHjournal]

Read this masterful state of the art review first presented at @isth 2023 in Montreal!

Immunothrombosis in neurovascular disease

@FrederikDenorme @abigail_ajanel @racampbell04

Read here ➡️:https://t.co/ImPLcWq5sP

[Iván Pinos Cabezas @ivan_pinos]

Excited to attend this webinar on Microfluidics Devices in Hemostasis organized by @isth https://t.co/spVHbsMjp3

[Andrew Akbashev @Andrew_Akbashev]

Not able to produce “favorable results” in the lab? You are a “loser”.

Stay in the shadows of those who can bring cool data to the Big Prof.

Sounds familiar? It's not only about this case at Stanford.

It's about academic culture in general:

- Keep pushing for metrics. Quantity over quality. Look for flashy conclusions.

- Skyrocket your profile. Build your research enterprise. Outcompete everyone in your field.

Isn’t it how academia works today? 🤨

▫️

Albert Einstein remarked: “An academic career, in which a person is forced to produce scientific writings in great amounts, creates a danger of intellectual superficiality”. 

Peter Higgs said he could NOT replicate his discovery in today’s academic climate: “Not enough peace and quiet in the present sort of climate to do what I did in 1964”.

▫️

Wonder about the results of this “culture”?

1. Thousands of FAKE research articles are published. 30% of all scientific articles may be fake products of paper mills. There is even a special lengthy page on Wiki called “Replication crisis”.

2. Life-draining tenure requirements that fuel the rat race. Why? To ensure the university ranking and recognition is going up.

3. Most PhDs don’t see themselves in science anymore. In many places, you are not required to be creative and knowledgable. Instead, you should demonstrate you can win a race.

Everyone knows it but few things change.

▫️

I am happy that Stanford showed courage and carried out investigation. It is an excellent example of HOW to react to manipulated papers and unhealthy lab dynamic.

It's just another reminder that:

We should STOP focusing on taking “professional selfies”.

We should STOP trading our passion for glory.

Focus on science instead

#AcademicChatter #AcademicTwitter #phdchat

[Tessa Barrett 👩‍🔬🧫🫀🧬🗽🇦🇺 @TessaJBarrett]

Delighted to have received my first R01!🥳
Incredibly grateful for all the advice & support @Plateletdoc, @KathrynMooreLab & others within the @NYULHCVRC & beyond🌏 thx you!
Looking forward to continuing our atherothrombosis res. into novel platelet activity regulators 🫀🧬🔬🧪